Exact Mass: 413.07331780000004

Exact Mass Matches: 413.07331780000004

Found 11 metabolites which its exact mass value is equals to given mass value 413.07331780000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Fosdevirine

5-Chloro-3-{[3-(2-cyanoeth-1-en-1-yl)-5-methylphenyl](methoxy)phosphoroso}-1H-indole-2-carboximidate

C20H17ClN3O3P (413.0696012)


   

CJ-42794

(S)-4-(1-(5-chloro-2-(4-fluorophenoxy)benzamido)ethyl)benzoic acid

C22H17ClFNO4 (413.08300840000004)


   

Bretylium tosylate

Bretylium (tosylate)

C18H24BrNO3S (413.0660174000001)


C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BD - Antiarrhythmics, class iii C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Bretylium (tosylate) is an inhibitor of the presynaptic release of vasoconstrictor neurotransmitters. It is the sympathetic nerve and adrenergic ganglion blocking agent . (1) Bretylium tosylate inhibits adrenergic function presynaptically only after an initial release in neurotransmitter substance. (2) The reference for administration dose is 15 mg/kg (I.P).

   

Alofanib

Alofanib

C19H15N3O6S (413.06815300000005)


   

10-Methyl-9-(phenoxycarbonyl)acridinium fluorosulfonate

10-Methyl-9-(phenoxycarbonyl)acridinium fluorosulfonate

C21H16FNO5S (413.07331780000004)


   

Fosdevirine

Unii-Z4I0C281BJ

C20H17ClN3O3P (413.0696012)


C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent

   

4-Methyl-3-nitrobenzoic acid [6-[[(4-methyl-2-pyrimidinyl)thio]methyl]-4-oxo-3-pyranyl] ester

4-Methyl-3-nitrobenzoic acid [6-[[(4-methyl-2-pyrimidinyl)thio]methyl]-4-oxo-3-pyranyl] ester

C19H15N3O6S (413.06815300000005)


   

2-[5-(4-hydroxy-3-nitrobenzylidene)-2,4-dioxo-1,3-thiazolidin-3-yl]-N-(3-methylphenyl)acetamide

2-[5-(4-hydroxy-3-nitrobenzylidene)-2,4-dioxo-1,3-thiazolidin-3-yl]-N-(3-methylphenyl)acetamide

C19H15N3O6S (413.06815300000005)


   

methyl 1-(4-chlorophenyl)-5-[(E)-(phenylcarbamothioylhydrazinylidene)methyl]pyrazole-4-carboxylate

methyl 1-(4-chlorophenyl)-5-[(E)-(phenylcarbamothioylhydrazinylidene)methyl]pyrazole-4-carboxylate

C19H16ClN5O2S (413.07131860000004)


   

LPS 7:3;O3

LPS 7:3;O3

C13H20NO12P (413.0723090000001)


   

(Rac)-NMDAR antagonist 1

(Rac)-NMDAR antagonist 1

C20H20BrN3O2 (413.07388000000003)


(Rac)-NMDAR antagonist 1 is the racemate of NMDAR antagonist 1. NMDAR antagonist 1 is a potent and orally bioavailable NR2B-selective NMDAR antagonist[1].